Viatris Inc

Viatris Inc

World Rank (Aug-2026)
1316
Market Cap (Aug-2026)
18.642 Billion USD
World Rank (Jan-05-2024)
1,267
Market Cap (Jan-05-2024)
13.856 Billion USD
World Rank (Jul-30-2023)
1,399
Market Cap (Jul-30-2023)
12.470 Billion USD
World Rank (Jan-07-2022)
1,151
Market Cap (Jan-07-2022)
17.826 Billion USD
World Rank (Jan-01-2021)
817
Market Cap (Jan-01-2021)
22.529 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 534
Headquarters Country
USA
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Technology Companies in S&P 500
Top Healthcare Companies in S&P 500
Nasdaq / NYSE Code
VTRS
CEO
Michael Goettler
Employee Count
37,000
Employee Count as of Date
As on 2022
Headquarters City/State
Pennsylvania
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
14,250 Million USD
Annual Operating Income in USD
-2,663 Million USD
Annual Net Income in USD
-3,515 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
37,193 Million USD
Total Liabilities in USD
22,482 Million USD
Total Equity in USD
14,711 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Technology
HealthCare Products
Pharmaceutical
Company Website
MYLAN N.V.
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Facebook
Facebook
Company Profile

VIATRIS INC is a Pharmaceutical company. The headquarters is in Pennsylvania, USA.

VIATRIS INC better access to customers and patients in more than 165 countries and territories.

VIATRIS INC total number of employees in 2022 was 37,000.

VIATRIS INC annual revenue generated for period ending Dec-2022 was 16,262 million USD.

VIATRIS INC annual net income generated for period ending Dec-2022 was 2,078 million USD.

Annual Results Summary

VIATRIS INC - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-202216,2621,6552,078
Dec-202117,886295-1,269 (Loss)
Dec-202011,946-103 (Loss)-669 (Loss)
Dec-201911,50069416
Dec-201811,433856352
Balance Sheet Summary

Total Assets as on Dec-2022 was 50,022 Million USD.

Total Liabilities as on Dec-2022 was 28,949 Million USD.

Total Equity as on Dec-2022 was 21,072 Million USD.

Founded Year
1961
Stock Category
S&P 500
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Medicinal Chemicals and Botanical Products

Share